Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.36% |
| Sep 30, 2025 | -26.21% |
| Jun 30, 2025 | -16.42% |
| Mar 31, 2025 | 27.93% |
| Dec 31, 2024 | -6.26% |
| Sep 30, 2024 | -29.58% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -8.88% |
| Dec 31, 2023 | -29.22% |
| Sep 30, 2023 | -5.61% |
| Jun 30, 2023 | -55.78% |
| Mar 31, 2023 | -28.44% |
| Dec 31, 2022 | -60.79% |
| Sep 30, 2022 | 21.22% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | -35.15% |
| Dec 31, 2021 | -12.20% |
| Sep 30, 2021 | 26.14% |
| Jun 30, 2021 | -17.22% |
| Mar 31, 2021 | 4.47% |
| Dec 31, 2020 | 1.20% |
| Sep 30, 2020 | -32.15% |
| Jun 30, 2020 | 95.72% |
| Mar 31, 2020 | 143.78% |
| Dec 31, 2019 | -34.92% |
| Sep 30, 2019 | -10.99% |
| Jun 30, 2019 | -7.03% |
| Mar 31, 2019 | -35.23% |
| Dec 31, 2018 | -23.88% |
| Sep 30, 2018 | -356.01% |
| Jun 30, 2018 | -27.10% |
| Mar 31, 2018 | -19.92% |
| Dec 31, 2017 | 9.87% |
| Sep 30, 2017 | 4.96% |
| Jun 30, 2017 | -36.25% |
| Mar 31, 2017 | 0.77% |
| Dec 31, 2016 | 47.71% |
| Sep 30, 2016 | 15.51% |
| Jun 30, 2016 | 11.20% |
| Mar 31, 2016 | -27.86% |
| Dec 31, 2015 | 61.93% |
| Sep 30, 2015 | 45.04% |
| Jun 30, 2015 | 59.08% |